Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fiedler

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Der Urologe. Ausg. A|July 13, 2007
[Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma]G Bartsch, K Eggert, S Soker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
Seminars in Oncology|December 1, 1990
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphomaA D Ho, F Del Valle, R Haas, et al.
Clinical Immunology and Immunopathology|August 1, 1987
T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophagesW Fiedler, K W Sykora, K Welte, et al.
Journal of Neurochemistry|November 1, 1986
A kinetic study of stimulus-induced vesicle recycling in electromotor nerve terminals using labile and stable vesicle markersD V Agoston, G H Dowe, W Fiedler, et al.
Gene Therapy|November 17, 2017
SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse modelM Täger, S Horn, E Latuske, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2016
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomasW Fiedler, S DeDosso, S Cresta, et al.
Cancer|August 1, 1990
Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot studyA D Ho, F Del Valle, M Engelhard, et al.
Leukemia|February 10, 2011
Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemiaJ Otten, L Schmitz, E Vettorazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2010
Phase I trial of SU14813 in patients with advanced solid malignanciesW Fiedler, G Giaccone, P Lasch, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Der Urologe. Ausg. A|July 13, 2007
[Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma]G Bartsch, K Eggert, S Soker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
Seminars in Oncology|December 1, 1990
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphomaA D Ho, F Del Valle, R Haas, et al.
Clinical Immunology and Immunopathology|August 1, 1987
T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophagesW Fiedler, K W Sykora, K Welte, et al.
Journal of Neurochemistry|November 1, 1986
A kinetic study of stimulus-induced vesicle recycling in electromotor nerve terminals using labile and stable vesicle markersD V Agoston, G H Dowe, W Fiedler, et al.
Gene Therapy|November 17, 2017
SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse modelM Täger, S Horn, E Latuske, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2016
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomasW Fiedler, S DeDosso, S Cresta, et al.
Cancer|August 1, 1990
Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot studyA D Ho, F Del Valle, M Engelhard, et al.
Leukemia|February 10, 2011
Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemiaJ Otten, L Schmitz, E Vettorazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2010
Phase I trial of SU14813 in patients with advanced solid malignanciesW Fiedler, G Giaccone, P Lasch, et al.
Pageof 14